These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia. van Sonderen A; Wirtz PW; Verschuuren JJ; Titulaer MJ Curr Treat Options Neurol; 2013 Apr; 15(2):224-39. PubMed ID: 23263888 [TBL] [Abstract][Full Text] [Related]
5. Maintenance immunosuppression in myasthenia gravis. Gotterer L; Li Y J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912 [TBL] [Abstract][Full Text] [Related]
6. Current and future standards in treatment of myasthenia gravis. Gold R; Schneider-Gold C Neurotherapeutics; 2008 Oct; 5(4):535-41. PubMed ID: 19019304 [TBL] [Abstract][Full Text] [Related]